189 related articles for article (PubMed ID: 35743189)
1. Modified Fluoroquinolones as Antimicrobial Compounds Targeting
Vu TH; Adhel E; Vielfort K; Ha Duong NT; Anquetin G; Jeannot K; Verbeke P; Hjalmar S; Gylfe Å; Serradji N
Int J Mol Sci; 2022 Jun; 23(12):. PubMed ID: 35743189
[No Abstract] [Full Text] [Related]
2. In vitro activities of a new fluoroquinolone derivative highly active against Chlamydia trachomatis.
Vu TH; Ha-Duong NT; Aubry A; Capton E; Fechter P; Plésiat P; Verbeke P; Serradji N
Bioorg Chem; 2019 Mar; 83():180-185. PubMed ID: 30380446
[TBL] [Abstract][Full Text] [Related]
3. [Infections with Chlamydia trachomatis].
Stock I; Henrichfreise B
Med Monatsschr Pharm; 2012 Jun; 35(6):209-22; quiz 223-4. PubMed ID: 22808665
[TBL] [Abstract][Full Text] [Related]
4. Aminomethyl Spectinomycins as Therapeutics for Drug-Resistant Gonorrhea and Chlamydia Coinfections.
Butler MM; Waidyarachchi SL; Connolly KL; Jerse AE; Chai W; Lee RE; Kohlhoff SA; Shinabarger DL; Bowlin TL
Antimicrob Agents Chemother; 2018 May; 62(5):. PubMed ID: 29483122
[TBL] [Abstract][Full Text] [Related]
5. Inhibition of Chlamydia trachomatis Growth During the Last Decade: A Mini-Review.
Serradji N; Vu TH; Kim H; Panyam J; Verbeke P
Mini Rev Med Chem; 2018; 18(16):1363-1372. PubMed ID: 29692244
[TBL] [Abstract][Full Text] [Related]
6. Mass drug administration of azithromycin for trachoma reduces the prevalence of genital Chlamydia trachomatis infection in the Solomon Islands.
Marks M; Bottomley C; Tome H; Pitakaka R; Butcher R; Sokana O; Kako H; Solomon AW; Mabey DC
Sex Transm Infect; 2016 Jun; 92(4):261-5. PubMed ID: 26888658
[TBL] [Abstract][Full Text] [Related]
7. Acute pelvic inflammatory disease.
Eschenbach DA
Urol Clin North Am; 1984 Feb; 11(1):65-81. PubMed ID: 6369707
[TBL] [Abstract][Full Text] [Related]
8. In vitro activity of lomefloxacin against Chlamydia trachomatis, Neisseria gonorrhoeae, Haemophilus ducreyi, Mycoplasma hominis, and Ureaplasma urealyticum.
Hoban D; DeGagne P; Witwicki E
Diagn Microbiol Infect Dis; 1989; 12(3 Suppl):83S-86S. PubMed ID: 2507222
[TBL] [Abstract][Full Text] [Related]
9. In vitro activity of fluoroquinolones, azithromycin and doxycycline against chlamydia trachomatis cultured from men with chronic lower urinary tract symptoms.
Smelov V; Perekalina T; Gorelov A; Smelova N; Artemenko N; Norman L
Eur Urol; 2004 Nov; 46(5):647-50. PubMed ID: 15474277
[TBL] [Abstract][Full Text] [Related]
10. [Sexually transmitted diseases produced by Chlamydia trachomatis and their treatment].
Perea Pérez EJ
Rev Clin Esp; 1998 Sep; 198 Suppl 1():44-50. PubMed ID: 9835774
[No Abstract] [Full Text] [Related]
11. [Chlamydia trachomatis infections].
Széll A; Szalka A
Orv Hetil; 1998 Nov; 139(46):2767-73. PubMed ID: 9849062
[TBL] [Abstract][Full Text] [Related]
12. Use of quinolones in chlamydial infection.
Oriel JD
Rev Infect Dis; 1989; 11 Suppl 5():S1273-6. PubMed ID: 2672254
[TBL] [Abstract][Full Text] [Related]
13. The role of fluoroquinolones in sexually transmitted diseases.
Tartaglione TA; Hooton TM
Pharmacotherapy; 1993; 13(3):189-201. PubMed ID: 8321733
[TBL] [Abstract][Full Text] [Related]
14. Synthesis and biological evaluation of sulfonylpyridine derivatives as potential anti-chlamydia agents.
Feng J; Janaína de Campos L; Seleem MA; Conda-Sheridan M
Bioorg Med Chem; 2023 Aug; 91():117401. PubMed ID: 37453189
[TBL] [Abstract][Full Text] [Related]
15. Effect of bovine lactoferrin on Chlamydia trachomatis infection and inflammation.
Sessa R; Di Pietro M; Filardo S; Bressan A; Rosa L; Cutone A; Frioni A; Berlutti F; Paesano R; Valenti P
Biochem Cell Biol; 2017 Feb; 95(1):34-40. PubMed ID: 28094551
[TBL] [Abstract][Full Text] [Related]
16. In vitro activities of lomefloxacin, tetracycline, penicillin, spectinomycin, and ceftriaxone against Neisseria gonorrhoeae and Chlamydia trachomatis.
Talbot H; Romanowski B
Antimicrob Agents Chemother; 1989 Dec; 33(12):2049-51. PubMed ID: 2533473
[TBL] [Abstract][Full Text] [Related]
17. In vitro activity of the two new 4-quinolones A56619 and A56620 against Neisseria gonorrhoeae, Chlamydia trachomatis, Mycoplasma hominis, Ureaplasma urealyticum and Gardnerella vaginalis.
Tjiam KH; Wagenvoort JH; van Klingeren B; Piot P; Stolz E; Michel MF
Eur J Clin Microbiol; 1986 Oct; 5(5):498-501. PubMed ID: 3096726
[TBL] [Abstract][Full Text] [Related]
18. Azithromycin. A pharmacoeconomic review of its use as a single-dose regimen in the treatment of uncomplicated urogenital Chlamydia trachomatis infections in women.
Lea AP; Lamb HM
Pharmacoeconomics; 1997 Nov; 12(5):596-611. PubMed ID: 10174326
[TBL] [Abstract][Full Text] [Related]
19. Uncommon occurrence of fluoroquinolone resistance-associated alterations in GyrA and ParC in clinical strains of Chlamydia trachomatis.
Yokoi S; Yasuda M; Ito S; Takahashi Y; Ishihara S; Deguchi T; Maeda S; Kubota Y; Tamaki M; Fukushi H
J Infect Chemother; 2004 Oct; 10(5):262-7. PubMed ID: 16163459
[TBL] [Abstract][Full Text] [Related]
20. Double-blind comparison of trovafloxacin and doxycycline in the treatment of uncomplicated Chlamydial urethritis and cervicitis. Trovafloxacin Chlamydial Urethritis/Cervicitis Study Group.
McCormack WM; Dalu ZA; Martin DH; Hook EW; Laisi R; Kell P; Pluck ND; Johnson RB
Sex Transm Dis; 1999 Oct; 26(9):531-6. PubMed ID: 10534208
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
